Eye fluid analysis may unlock secrets of rare eye condition

NCT ID NCT07506551

Ongoing Knowledge-focused Sponsor: Prim. Prof. Dr. Oliver Findl, MBA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study examines proteins in the vitreous (the gel-like fluid inside the eye) of patients with pseudoexfoliation syndrome (PEX), a condition that can lead to glaucoma. Researchers will compare protein levels between eyes with and without PEX in 24 adults undergoing eye surgery for other reasons. The goal is to better understand the biology of PEX, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal protein markers that help understand pseudoexfoliation syndrome, potentially pointing toward future diagnostic or treatment targets.
What could go wrong: This is a very small pilot study (24 participants) that only observes protein levels, not a treatment trial. It may not lead to any direct medical advances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIRETINAL MEMBRANE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome exfoliation syndrome, susceptibility to macular holes preretinal fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSEUDOEXFOLIATION SYNDROME

Contacts and locations

Locations

Vienna Institute for Research in Ocular Surgery (VIROS)

Vienna, 1140, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.